Led by Garnet Anderson, latest Women's Health Initiative study shows more than 20 percent reduction in cancer risk, 63 percent reduction in deaths for short-term estrogen users
March 12, 2012
Women who used the estrogen-only form of hormone replacement therapy were more than 20 percent less likely to develop breast cancer and remained significantly less likely to die from the disease than those who never used HRT, according to new Fred Hutchinson Cancer Research Center research led by Dr. Garnet Anderson, left.
Women’s Health Initiative substudy shows small, consistent mammographic changes
Nov. 23, 2009
| By Colleen Steelquist
A Women’s Health Initiative ancillary study by Fred Hutchinson Cancer Research Center scientists concludes that estrogen-alone hormone therapy causes a sustained and modest increase in mammographic density in postmenopausal women, a risk factor for breast cancer. The results of the study were published online Nov. 10 in the Journal of Clinical Oncology.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.